Author Question: Which laboratory results are goals for reducing a person's risk for diabetes and heart disease? ... (Read 68 times)

joe · **on:** Jul 11, 2018

Which laboratory results are goals for reducing a person's risk for diabetes and heart disease?

a. Triglycerides over 150 mg/dl
b. Cholesterol 250 mg/dl
c. High-density lipoprotein (HDL) over 40 mg/d
d. Fasting blood glucose under 150 mg/dl

Question 2

The nurse assesses a resident who was transferred yesterday from an acute care hospital. Which should the nurse assess to determine whether this individual is under stress from the transfer?

a. Length of the resident's stay in the acute care facility
b. Availability of disposition options before the transfer
c. Presence of familiar people throughout the transfer
d. Tour of the new facility shortly after transfer

Melissahxx · **Reply #1 on:** Jul 11, 2018

Answer to Question 1

C
To reduce the risk for diabetes and heart disease, the serum triglycerides value should be under 150 mg/dl. The cholesterol value should be under 200 mg/dl to reduce the risk for heart disease and diabetes. The HDL level should be over 40 mg/dl to reduce the risk for heart disease and di-abetes. Fasting blood glucose value should be under 126 mg/dl.

Answer to Question 2

B
To help assess the resident for stress, the nurse reviews the sequence of events that led to the re-location including whether the resident had relocation options and what those options were be-fore relocation. If the resident played an active role in the choice of facilities and had several available options, then the resident is likely to experience less stress upon relocation. The length of stay in the acute care facility is an unreliable index of stress in a resident who has been re-cently relocated. The presence of familiar people is an unreliable predictor of relocation stress. Touring the new facility is an unreliable predictor of relocation stress; if the tour is conducted too soon or when the resident is in pain, tired, or distracted, then the resident is unlikely to benefit from the tour.